Orlinger Klaus 4
4 · HOOKIPA Pharma Inc. · Filed Apr 24, 2020
Insider Transaction Report
Form 4
Orlinger Klaus
Sr. VP, Research
Transactions
- Award
Stock Option (Right to Buy)
2020-04-20+30,000→ 0 totalExercise: $8.03Exp: 2030-04-20→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on February 15, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.